Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

KRYSKRYS
19 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in Krystal Biotech, Inc.

Avoro Capital Advisors LLC holds 2.9M shares of KRYS (Krystal Biotech, Inc.), worth $1.1B as of 2026-Q2. KRYS represents 9.6% of Avoro Capital Advisors LLC's portfolio.

Current Value

$1.1B

Current Shares

2.9M

Total Value Change

+$1B

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2.9M
0.0%
$1.1B9.6%$371.67
0
2026-Q1
Unchanged
2.9M
0.0%
$746.3M7.3%$263.80
0
2025-Q4
Increased
2.9M
+4.0%
$712.2M7.0%$247.88
65
2025-Q3
Increased
2.8M
+4.4%
$490.4M6.3%$176.75
65
2025-Q2
Decreased
2.7M
-2.6%
$365.6M6.4%$138.88
0
2025-Q1
Increased
2.7M
+3.9%
$492.4M7.7%$183.92
64
2024-Q4
Increased
2.6M
+0.3%
$411.8M5.8%$159.80
61
2024-Q3
Increased
2.6M
+7.8%
$477.3M7.0%$177.14
67
2024-Q2
Decreased
2.4M
-4.8%
$446.8M6.0%$183.64
0
2024-Q1
Decreased
2.6M
-0.4%
$454.7M5.3%$177.93
0
2023-Q4
Unchanged
2.6M
0.0%
$318.3M4.4%$124.06
0
2023-Q3
Increased
2.6M
+0.2%
$297.6M4.6%$116.00
58
2023-Q2
Increased
2.6M
+46.3%
$300.6M4.1%$115.67
78
2023-Q1
Increased
1.8M
+24.1%
$140.1M2.1%$79.35
64
2022-Q4
Increased
1.4M
+10.6%
$111.7M1.7%$79.22
53
2022-Q3
Increased
1.3M
+18.6%
$88.9M1.6%$70.56
56
2022-Q2
Increased
1.1M
+7.0%
$70.6M1.4%$64.66
51
2022-Q1
Increased
1M
+111.6%
$66.9M1.2%$66.90
76
2021-Q4
New
475,000
-
$33.2M0.6%$70.50
57

Other major holders of KRYS: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used